GENAZZANI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 48403
EU - Europa 13118
AS - Asia 5581
AF - Africa 50
SA - Sud America 30
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 19
Totale 67229
Nazione #
US - Stati Uniti d'America 46860
CN - Cina 3739
SE - Svezia 2987
BG - Bulgaria 2272
IT - Italia 2153
UA - Ucraina 2124
CA - Canada 1529
DE - Germania 1227
TR - Turchia 882
VN - Vietnam 844
FI - Finlandia 829
GB - Regno Unito 646
FR - Francia 298
RU - Federazione Russa 209
BE - Belgio 138
NL - Olanda 47
CI - Costa d'Avorio 33
IN - India 29
EU - Europa 28
RO - Romania 26
KR - Corea 24
GR - Grecia 22
BR - Brasile 21
ES - Italia 20
AU - Australia 18
IE - Irlanda 17
PT - Portogallo 14
DK - Danimarca 13
MX - Messico 13
PL - Polonia 13
HU - Ungheria 12
IL - Israele 12
CH - Svizzera 11
HK - Hong Kong 11
CZ - Repubblica Ceca 10
JP - Giappone 8
CL - Cile 6
EE - Estonia 6
HR - Croazia 6
ID - Indonesia 6
NG - Nigeria 6
AT - Austria 5
SG - Singapore 5
MY - Malesia 4
EG - Egitto 3
IS - Islanda 3
MA - Marocco 3
TH - Thailandia 3
TW - Taiwan 3
AL - Albania 2
IR - Iran 2
SA - Arabia Saudita 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CO - Colombia 1
CY - Cipro 1
IM - Isola di Man 1
JM - Giamaica 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
SD - Sudan 1
SI - Slovenia 1
Totale 67229
Città #
Woodbridge 8160
Ann Arbor 5939
Houston 5452
Fairfield 5347
Chandler 3680
Jacksonville 2853
Sofia 2271
Seattle 2216
Ashburn 2212
Wilmington 2026
Cambridge 1867
Ottawa 1494
Beijing 1127
Nanjing 900
Izmir 870
Princeton 849
Lawrence 841
Medford 806
Des Moines 630
Jüchen 504
Dearborn 497
Dong Ket 386
Nanchang 326
San Diego 236
Falls Church 212
Kunming 191
Shenyang 161
Boulder 160
Brussels 137
Hebei 137
Changsha 133
Milan 132
Marseille 131
Tianjin 117
Lancaster 115
Norwalk 115
Hefei 104
Jiaxing 99
Redwood City 93
Orange 86
Frankfurt am Main 73
Verona 71
Hangzhou 63
Düsseldorf 58
Serra 46
Jinan 43
Lanzhou 39
Changchun 38
Indiana 38
Guangzhou 34
Abidjan 33
Boardman 32
London 32
Detroit 29
Zhengzhou 29
Shanghai 27
Ningbo 26
New York 24
Los Angeles 23
San Francisco 23
Chicago 21
Toronto 21
Pisa 18
Chengdu 17
Auburn Hills 16
Seacroft 16
Taizhou 16
Amsterdam 13
Madrid 12
Copenhagen 11
Stockholm 11
Xian 11
Boston 10
Budapest 9
Dublin 9
Florence 9
Monmouth Junction 9
Redmond 9
Walnut 9
Baotou 8
Chongqing 8
Dallas 8
Fuzhou 8
Helsinki 8
Warsaw 8
Wenzhou 8
Yellow Springs 8
Hanover 7
Leawood 7
Mumbai 7
St Louis 7
Athens 6
Augusta 6
Bengaluru 6
Bremen 6
Jinhua 6
Munich 6
Prague 6
Wuhan 6
Ypsilanti 6
Totale 54786
Nome #
Menopause, Hormone Replacement Therapy (HRT) and Obesity 279
Plasma and CSF endorphin levels in primary and symptomatic headaches. 151
Clinical and endocrinological investigations on superovulation induced in heifers by human menopausal gonadotrophin. 139
Plasma thyrotrophin levels during pregnancy. 138
Estimation of instantaneous secretory rate of luteinizing hormone in women during the menstrual cycle and in men. 138
Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. 137
Oestradiol/progesterone imbalance and the premenstrual syndrome. 135
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells 133
Endogenous opioid inhibitory tone on LH secretion in normal puberty and in several pubertal disturbances. 130
Dydrogesterone increases allopregnanolone in selected brain areas and in serum of female rats 130
Nomifensine: diagnostic test in hyperprolactinemic states. 129
Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations. 129
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome 129
Adrenal and gonadal steroids and pituitary response to LHRH in girls. II. Precocious puberty. 128
Prolactin responsiveness to nomifensine in patients with hyperprolactinemia of tumorous or uncertain etiology. 128
Presence of acetylated and shortened endorphins in human fetal pituitary gland. 128
Pharmacotherapy: Benefits of menopausal hormone therapy--timing is key. 127
Plasma levels of gonadotropins, prolactin, thyroxine, and adrenal and gonadal steroids in obese prepubertal girls. 126
Different rebound rise in plasma prolactin during the postdopamine infusion phase in puerperal women and patients with pathological hyperprolactinemia 126
Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine. 126
Plasma androgens and menstrual cycle: physiopathological correlates from adolescence to menopause. 126
Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise. 126
Factors associated with pain complaints in a clinical sample of postmenopausal women. 126
Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy. 126
Adrenal and gonadal steroids in girls during sexual maturation. 125
Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H-naloxone binding. 125
Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. 125
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists. 124
Pituitary response to hypoglycemia in pituitary diseases. 124
Concomitant increase in nociceptive flexion reflex threshold and plasma opioids following transcutaneous nerve stimulation. 124
Secretion pattern of endogenous opioids in chronic schizophrenia. 124
Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition. 124
Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. 124
Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. 124
Proopiomelanocortin-related peptides and methionine enkephalin in human follicular fluid: changes during the menstrual cycle. 123
Pituitary proopiomelanocortin peptides in mental disorders. 123
Opioids and testicular activity in the frog, Rana esculenta. 123
Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency 123
The relative contributions of menopause and aging to postmenopausal reduction in intervertebral disk height 123
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 123
Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia. 122
Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. 122
Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. 122
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women. 121
Fetal intermediate lobe is stimulated by parturition 121
Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas. 121
Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women 121
Optimizing quality of life through sex steroids by their effects on neurotransmitters 121
Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion. 120
Premenstrual increase of intracellular magnesium levels in women with ovulatory, asymptomatic menstrual cycles. 120
Abnormal beta-endorphin and beta-lipotropin responses to TRH and LRH administration in primary and secondary affective disorders. 119
Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hypothalamic amenorrhea 118
L-arginine infusion reduces preterm uterine contractions. 118
A personal initiative for women's health: to challenge the Women's Health Initiative. 118
Pulsed estrogen exposure selectively modulates tissue response: a hypothesis 118
Effect of two serotonin antagonists on prolactin release induced by breast stimulation in postpartum women. 118
Effect of piribedil on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia. 117
Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia. 117
Plasma levels of luteinizing hormone, estradiol and androstenedione in sows with inadequate plasma progesterone. 117
Absent B-endorphin response to clonidine in obese children. 117
Glucocorticoids but not vasopressin or oxytocin inhibit luteinizing hormone secretion in patients with psychogenic amenorrhea. 117
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 117
Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women. 117
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea. 117
Adrenal and gonadal steroids and pituitary response to LHRH in girls. I. Delayed puberty. 116
Placental impermeability to maternal ACTH in the rabbit. 116
Cytogenetic study on 282 patients with suspected chromosomal aberration. 116
Domperidone in defective and insufficient lactation. 116
Menstrual-related mood changes in patients with oligomenorrhea. 116
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea. 116
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists. 116
A review of the cardiovascular and breast actions of drospirenone in preclinical studies. 116
A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine test. 116
Plasma opioid levels in post-traumatic chronic headache and trigeminal neuralgia: maintained response to acupuncture. 115
Presence and synthesis of inhibin subunits in human decidua. 115
Abnormal dexamethasone suppression test in daily chronic headache sufferers. 115
Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. 115
Hormone replacement therapy and endometrial, ovarian and colorectal cancer 115
Endothelium and estrogen receptors 115
Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause 115
Impaired beta-endorphin response to human corticotropin-releasing hormone in obese children 115
Human chorionic somato-mammotropine (HCSM): lipolytic action of a pure preparation on isolated fat cells. 114
Reduced testosterone levels in cluster headache: a stress-related phenomenon? 114
The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors. 114
Opioid control of gonadotrophin secretion in humans 114
The HRT misuse and osteoporosis epidemic: a possible future scenario 114
Effect of short dexamethasone suppression on plasma steroids in prepubertal and pubertal girls. 114
Neuroendocrine effects of flunarizine treatment in postmenopausal women. 113
Acute beta-interferon or thymopentin administration increases plasma growth hormone and cortisol levels in children. 113
Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor 113
Why kisspeptin is such important for reproduction? 113
Skeletal status and body composition in young women with functional hypothalamic amenorrhea. 113
Impaired reduction of enhanced levels of dehydroepiandrosterone by oral dexamethasone in anorexia nervosa. 113
Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome 113
Neuroendocrine evidence of deranged noradrenergic activity in chronic migraine 113
Doppler ultrasound studies of the uterine arteries in spontaneous and IVF stimulated ovarian cycles. 112
Estrogens modulate the circadian rhythm of hypothalamic beta-endorphin contents in female rats. 112
The association of menstrual migraine with the premenstrual syndrome. 112
High levels of serum allopregnanolone in women with premature ovarian failure 112
Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats. 111
Totale 12238
Categoria #
all - tutte 98855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181265 0000 00 00 8348764946
2018/201910624 61583026 1220105 279496 95187424041861
2019/202014566 179813403001029 17631582 17971143 16657491156244
2020/20217218 821288740365 884245 566694 4676384051105
2021/20228772 72341137741 19431361 180386 6232263042458
2022/20237669 1193702344799 12311315 126770 1189000
Totale 67680